Marc Stapley
Director at GLAUKOS Corp (GKOS); CEO at Veracyte, Inc. (VCYT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 4SEC | VCYTVeracyte, Inc. | Sell Plan | 138,051440,494 held (−24%) | $50.12 | $6.9M | -9.8% |
| Mar 6SEC | VCYTVeracyte, Inc. | Sell Plan | 19,244383,833 held (−5%) | $35.56 | $684K | +27.2% |
| Mar 6SEC | VCYTVeracyte, Inc. | Sell Plan | 26,279357,554 held (−7%) | $36.28 | $953K | +24.7% |
| Jan 26SEC | GKOSGLAUKOS Corp | Sell Plan | 3,81248,637 held (−7%) | $126.07 | $481K | +31.4% |
| Jan 26SEC | GKOSGLAUKOS Corp | Sell Plan | 3,89244,745 held (−8%) | $126.96 | $494K | +30.5% |
| Jan 26SEC | GKOSGLAUKOS Corp | Sell Plan | 1,67143,074 held (−4%) | $127.92 | $214K | +29.5% |
| Jan 26SEC | GKOSGLAUKOS Corp | Sell Plan | 4,32538,749 held (−10%) | $129.11 | $558K | +28.3% |
| Jan 26SEC | GKOSGLAUKOS Corp | Sell Plan | 1,30037,449 held (−3%) | $129.78 | $169K | +27.7% |
| Dec 4SEC | VCYTVeracyte, Inc. | Sell Plan | 4,448321,823 held (−1%) | $46.90 | $209K | -3.6% |
| Dec 4SEC | VCYTVeracyte, Inc. | Sell Plan | 3,220318,603 held (−1%) | $47.35 | $152K | -4.5% |
- Sell
CEO Marc Stapley sold $6.9M of VCYT at $50.12 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Marc Stapley sold $684K of VCYT at $35.56 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Marc Stapley sold $953K of VCYT at $36.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Marc Stapley sold $481K of GKOS at $126.07 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Marc Stapley sold $494K of GKOS at $126.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Marc Stapley sold $214K of GKOS at $127.92 — pre-scheduled 10b5-1 plan sale.